N
Neurogene
New York, United States
Founded 2018 NASDAQ: NGNE
Gene Therapy Delivery Nanomedicine Nano-Bio Regenerative Medicine Nanosequencing Protein Nanoparticles
About
Gene therapy company developing treatments for rare neurological diseases in children
Company Details
- Type
- public
- Employees
- 100+
- Funding
- Public
Key Products
- NGN-401
- NGN-101
- EXACT Technology